Modular Phase 1B Hypothesis-Testing, Biomarker-Driven, Talazoparib Combination Trial (TalaCom)
Latest Information Update: 30 Aug 2024
At a glance
- Drugs Axitinib (Primary) ; Crizotinib (Primary) ; Palbociclib (Primary) ; Talazoparib (Primary)
- Indications Prostate cancer; Solid tumours
- Focus Adverse reactions
- Acronyms TalaCom
- 07 Jan 2021 New trial record